Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
PLoS One. 2013 May 29;8(5):e64975. doi: 10.1371/journal.pone.0064975. Print 2013.
The chemokine receptor CXCR4 regulates cell migration during ontogenesis and disease states including cancer and inflammation. Upon stimulation by the endogenous ligand CXCL12, CXCR4 becomes phosphorylated at multiple sites in its C-terminal domain. Mutations in the CXCR4 gene affecting C-terminal phosphorylation sites are a hallmark of WHIM syndrome, a genetic disorder characterized by a gain-of-CXCR4-function. To better understand how multi-site phosphorylation of CXCR4 is organized and how perturbed phosphorylation might affect CXCR4 function, we developed novel phosphosite-specific CXCR4 antibodies and studied the differential regulation and interaction of three C-terminal phosphorylation sites in human embryonic kidney cells (HEK293). CXCL12 promoted a robust phosphorylation at S346/347 which preceded phosphorylation at S324/325 and S338/339. After CXCL12 washout, the phosphosites S338/339 and S324/325 were rapidly dephosphorylated whereas phosphorylation at S346/347 was long-lasting. CXCL12-induced phosphorylation at S346/347 was staurosporine-insensitive and mediated by GRK2/3. WHIM syndrome-associated CXCR4 truncation mutants lacking the S346/347 phosphosite and the recently identified E343K WHIM mutant displayed strongly impaired phosphorylation at S324/325 and S338/339 as well as reduced CXCL12-induced receptor internalization. Relevance of the S346-S348 site was confirmed by a S346-348A mutant showing strongly impaired CXCL12-promoted phosphorylation at S324/325 and S338/339, defective internalization, gain of calcium mobilization, and reduced desensitization. Thus, the triple serine motif S346-S348 contains a major initial CXCR4 phosphorylation site and is required for efficient subsequent multi-site phosphorylation and receptor regulation. Hierarchical organization of CXCR4 phosphorylation explains why small deletions at the extreme CXCR4 C terminus typically associated with WHIM syndrome severely alter CXCR4 function.
趋化因子受体 CXCR4 在胚胎发生和疾病状态(包括癌症和炎症)中调节细胞迁移。在内源性配体 CXCL12 的刺激下,CXCR4 在其 C 末端结构域的多个位点发生磷酸化。影响 C 末端磷酸化位点的 CXCR4 基因突变是 WHIM 综合征的一个标志,WHIM 综合征是一种遗传疾病,其特征是 CXCR4 功能获得。为了更好地理解 CXCR4 的多位点磷酸化如何组织以及磷酸化的扰动如何影响 CXCR4 功能,我们开发了新型磷酸化特异性 CXCR4 抗体,并在人胚肾细胞(HEK293)中研究了三个 C 末端磷酸化位点的差异调节和相互作用。CXCL12 促进 S346/347 的强烈磷酸化,该磷酸化先于 S324/325 和 S338/339 的磷酸化。CXCL12 洗脱后,S338/339 和 S324/325 磷酸化迅速去磷酸化,而 S346/347 磷酸化则持续时间较长。CXCL12 诱导的 S346/347 磷酸化对 staurosporine 不敏感,并由 GRK2/3 介导。缺乏 S346/347 磷酸化位点的 WHIM 综合征相关 CXCR4 截断突变体和最近发现的 E343K WHIM 突变体显示 S324/325 和 S338/339 的磷酸化明显受损,以及 CXCL12 诱导的受体内化减少。S346-348A 突变体强烈抑制 CXCL12 促进的 S324/325 和 S338/339 磷酸化、缺陷内化、钙动员增加和脱敏减少,证实了 S346-S348 位点的相关性。因此,三丝氨酸基序 S346-S348 包含 CXCR4 磷酸化的主要初始位点,并且是高效后续多位点磷酸化和受体调节所必需的。CXCR4 磷酸化的层次结构解释了为什么与 WHIM 综合征相关的 CXCR4 C 末端的小缺失通常会严重改变 CXCR4 功能。